Perspective Therapeutics CATX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$111.13M-7.8% | -$103.12M+2.5% | -$105.8M-11.4% | -$94.95M-11.5% | -$85.17M-7.4% | ||
| $3.65M+12.1% | $3.25M+10.2% | $2.95M+3.7% | $2.84M+6.0% | $2.68M+16.3% | ||
| $9.42M+5.1% | $8.97M+2.9% | $8.72M+2.4% | $8.51M+24.7% | $6.83M+26.8% | ||
| -$92.37M-12.0% | -$82.48M+2.3% | -$84.43M-30.3% | -$64.78M-20.6% | -$53.72M-194% | ||
| $14.95M+17.3% | $12.75M-42.8% | $22.29M-55.4% | $50.01M0.0% | $50M-8.1% | ||
| -$62.76M-252% | $41.23M+133% | -$125.91M+25.8% | -$169.64M+4.3% | -$177.2M+19.1% | ||
| $54K+3.8% | $52K+2.0% | $51K-5.6% | $54K+10.2% | $49K+2.1% | ||
| $164.71M+1,496% | $10.32M-3.2% | $10.66M-3.7% | $11.08M-91.7% | $133.03M-54.0% | ||
| —— | —— | —— | —— | —— | ||
| -$107.32M-12.7% | -$95.23M+10.8% | -$106.72M+7.0% | -$114.78M-10.7% | -$103.72M-42.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Perspective Therapeutics generate?
- Perspective Therapeutics (CATX) generated -$92.4M in operating cash flow over the trailing twelve months.
- What is Perspective Therapeutics's free cash flow?
- After $15.0M of capital expenditures, Perspective Therapeutics's free cash flow was -$107.3M over the trailing twelve months, down 3.5% year over year.
- Where does Perspective Therapeutics's cash flow data come from?
- Every line is extracted from Perspective Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
